Clinical trials in Brno – page 29

390 clinical trials in Brno, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in CzechiaKlinickeTesty.cz

Brno at a glance

390

clinical trials

Research sites1

Quick filters

390 trials in Brno

Open in trial search

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo

Czechia

Participants:18–64 years
Substances:Ocrelizumab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Investigational

Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History

Investigational

Czechia

Participants:0–17 years · 18–64 years
Substances:Taldefgrobep Alfa
Sponsor:Biohaven Pharmaceuticals Inc.

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Thrombotic thrombocytopenic purpura

Not recruiting

Registered drugNo placebo

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Caplacizumab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drug

Study of Venetoclax and Azacitidine for Patients with Untreated Acute Myeloid Leukemia Who Cannot Have Standard Induction Therapy

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Diffuse large B-cell lymphoma+2

Not recruiting

Registered drug

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Celgene Corp.

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Lenalidomide
Sponsor:Celgene Corp.

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Bayer AG

Contact Research Centre

Magnetic resonance imaging+1

Not recruiting

Registered drugNo placebo

Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Gadobutrol
Sponsor:Bayer AG

Contact Research Centre

Type IIa hyperlipidaemia

Not recruiting

Investigational

Study of MK-0616 for Adults with Familial Hypercholesterolemia

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Enlicitide Chloride
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Follicular lymphoma+2

Not recruiting

Registered drugNo placebo

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Lenalidomide
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Brno

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced cancer treatments, including studies for leukemia, prostate cancer, and gastric cancer.

Chronic Lymphocytic Leukemia
Metastatic Prostate Cancer
Esophageal Cancer
Advanced Breast Cancer

Studies evaluating novel therapeutic combinations and targeted treatments for various cancer types.

02 Autoimmune Conditions

Research focused on treating inflammatory disorders and autoimmune conditions, with particular emphasis on innovative therapies.

Ulcerative Colitis
Psoriatic Arthritis
Plaque Psoriasis
Multiple Sclerosis

Evaluating new biological treatments and their long-term effectiveness in managing chronic conditions.

03 Respiratory and Cardiovascular

Studies addressing respiratory diseases and heart conditions, focusing on prevention and treatment strategies.

Chronic Obstructive Pulmonary Disease
RSV Prevention
Heart Failure Prevention
Cardiovascular Risk Management

Testing innovative approaches to improve patient outcomes in respiratory and cardiac conditions.

Back to Czechia All countries